Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-006556
Filing Date
2025-03-07
Accepted
2025-03-07 07:08:13
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20250307_defa14a.htm DEFA14A 34246
2 EXHIBIT 10.1 ex_786926.htm EX-10.1 76358
3 EXHIBIT 99.1 ex_786927.htm EX-99.1 12448
4 logo.jpg GRAPHIC 3886
5 lucidlogo.jpg GRAPHIC 10529
  Complete submission text file 0001437749-25-006556.txt   144159
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 25717548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)